Winning the Oregon Medicaid Lottery: A Case Study on Medicaid’s Effect on Utilization, Finances, and Health Outcomes

Dec. 4, 2013
Noon-1:00 p.m. Eastern





Katherine Baicker, PhD
Professor of Health Economics in the Department of Health Policy and Management, Harvard School of Public Health
Moderator: Cori Uccello, Senior Health Fellow, American Academy of Actuaries


In 2008, Oregon expanded its Medicaid program to include 10,000 additional low-income adults. Given that many more qualified residents were likely to want to enroll the program, Oregon opened a waiting list and held a lottery to determine who would be allowed to enroll in the Medicaid program. This provided researchers an opportunity to study the utilization, finances, and health outcomes of those who were selected in the lottery compared to those who were not, isolating the causal effect of Medicaid from potentially confounding factors. The study led to some interesting conclusions.

Our speaker for this webinar:
  • Provided an overview of the study, including methods, assumptions, and data received
  • Examined the results from the study and what they mean
  • Explored some of the implications of the study - what it does and does not tell us about Medicaid expansion


Katherine Baicker, PhD
Professor of Health Economics in the Department of Health Policy and Management at the Harvard School of Public Health
Professor Baicker’s research focuses primarily on the factors that drive the distribution, generosity, and effectiveness of public and private health insurance, with a particular focus on health insurance finance and the effect of reforms on the distribution and quality of care. She also is a research associate at the National Bureau of Economic Research and an elected member of the Institute of Medicine. She is currently one of the leaders of a research program investigating the many effects of expanding health insurance coverage in the context of a randomized Medicaid expansion in Oregon.
Her research has been published in journals such as the New England Journal of Medicine, Health Affairs, and the Quarterly Journal of Economics, and has been featured in outlets such as the New York Times, the Wall Street Journal, and National Public Radio.
She has served as a Senate-confirmed Member of the President’s Council of Economic Advisers, where she played a leading role in the development of health policy. She currently serves on the Editorial Boards of Health Affairs, the Journal of Health Economics, and the Journal of Economic Perspectives; as a Director of Eli Lilly; as Chair of the Board of Directors of AcademyHealth; on the Massachusetts Group Insurance Commission; on the Congressional Budget Office’s Panel of Health Advisers; and as a Commissioner on the Medicare Payment Advisory Commission. Read more.